MA.20/NCIC CTG/TROG 03.05 - MA.20 - TROG Cancer Research

By w.paterson
23 June, 2021
0 Comments

A Phase III Study of Regional Radiation Therapy in Early Breast Cancer

Radiotherapy to the breast reduces the risk of cancer coming back for women with early breast cancer. This international study will determine if treating a larger area with radiotherapy can further improve the results.

Primary Sponsor

NCIC CTG

Collaborating Groups

Trans Tasman Radiation Oncology Group (TROG)

Final Accrual

180

Trial Chairperson

International: Prof Timothy J. Whelan
TROG: A/Prof Boon Chua

Trial Contact

ymurray@ctg.queensu.ca

Clinical Trial Registration

Registration Link

8 July, 2025

Recruitment Milestone Achieved for TROG 19.06 DECREASE Trial

TRIAL UPDATE: 8 July 2025 The TROG 19.06 DECREASE

Geoff Zipper - aka Swamp - on the Kokoda Trail

26 June, 2025

A Phase III Study of Regional Radiation Therapy in Early Breast Cancer

TROG 05.01 – POST

ALLG/HDNLHL04/TROG 03.03

Related Post

Recruitment Milestone Achieved for TROG 19.06 DECREASE Trial

Cancer Survivor to Take on Fifth Kokoda trek to Support TROG